Kewaunee Scientific CORP /De/ (KEQU) — SEC Filings

Overview

Kewaunee Scientific CORP /De/ (KEQU) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Dec 12, 2025: KEWAUNEE SCIENTIFIC CORP /DE/ reported a significant increase in net sales for the three months ended October 31, 2025, reaching $70.096 million, up from $47.764 million in the prior year, a 46.7% increase. For the six months, net sales grew to $141.200 million from $96.157 million, a 46.8% increase

Sentiment Summary

Across 40 filings, the sentiment breakdown is: 2 bullish, 1 bearish, 36 neutral, 1 mixed. The dominant filing sentiment for Kewaunee Scientific CORP /De/ is neutral.

Filing Type Overview

Kewaunee Scientific CORP /De/ (KEQU) has filed 6 10-Q, 25 8-K, 2 DEF 14A, 2 10-K, 1 8-K/A, 4 SC 13G/A with the SEC between Feb 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (40)

• Kewaunee Scientific Sales Soar Post-Acquisition, But Profitability Mixed — 10-Q · Dec 12, 2025 Risk: medium
  KEWAUNEE SCIENTIFIC CORP /DE/ reported a significant increase in net sales for the three months ended October 31, 2025, reaching $70.096 million, up from $47.76
• 8-K Filing — 8-K · Dec 10, 2025
• Kewaunee Scientific Corp. Enters New Agreement, Terminates Old — 8-K · Dec 4, 2025 Risk: medium
  On December 4, 2025, Kewaunee Scientific Corp. entered into a material definitive agreement and simultaneously terminated a prior material definitive agreement.
• Kewaunee Scientific Files 8-K — 8-K · Nov 26, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on November 26, 2025, reporting other events and financial statements. The filing details the company's principal e
• Kewaunee Scientific Soars on Nu Aire Boost, Net Sales Up 47% — 10-Q · Sep 12, 2025 Risk: medium
  KEWAUNEE SCIENTIFIC CORP /DE/ reported a strong financial performance for the three months ended July 31, 2025, with net sales increasing by 46.9% to $71.104 mi
• Kewaunee Scientific Corp Reports Director/Officer Changes & Financials — 8-K · Sep 11, 2025 Risk: medium
  Kewaunee Scientific Corporation filed an 8-K on September 11, 2025, reporting on events as of September 10, 2025. The filing covers the departure of directors o
• Kewaunee Scientific Files 8-K on Financials — 8-K · Sep 10, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on September 10, 2025, to report on its results of operations and financial condition, and to file financial statem
• Kewaunee Scientific Corp Files 8-K on Shareholder Votes — 8-K · Aug 29, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on August 29, 2025, reporting on matters submitted to a vote of security holders as of August 27, 2025. The filing
• Kewaunee Scientific Files 8-K — 8-K · Aug 27, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on August 27, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not
• Kewaunee Scientific Files 8-K — 8-K · Aug 27, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on August 27, 2025, reporting other events and financial statements. The filing confirms the company's incorporatio
• KEQU Sets Virtual Annual Meeting for August 27, Urges Shareholder Vote — DEF 14A · Jul 7, 2025 Risk: low
  Kewaunee Scientific Corp (KEQU) has filed its definitive proxy statement (DEF 14A) for its Annual Meeting of Stockholders scheduled for August 27, 2025, at 11:0
• KEQU's Retained Earnings Dip 5% Amid Share Buybacks — 10-K · Jul 2, 2025 Risk: medium
  KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) reported a fiscal year ending April 30, 2025, with significant financial shifts. The company's retained earnings decreased
• Kewaunee Scientific Files 8-K on Financials — 8-K · Jun 26, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on June 26, 2025, reporting events as of June 25, 2025. The filing pertains to Results of Operations and Financial
• Kewaunee Scientific Files 8-K — 8-K · Jun 11, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on June 11, 2025, reporting on other events and financial statements. The filing does not contain specific details
• Kewaunee Scientific Q3 2025 Results Filed — 10-Q · Mar 14, 2025 Risk: low
  Kewaunee Scientific Corp reported its third-quarter results for the period ending January 31, 2025. The company's financial performance for this quarter and yea
• Kewaunee Scientific Files 8-K on Financials — 8-K · Mar 12, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on March 12, 2025, reporting on its results of operations and financial condition, and filing financial statements
• Kewaunee Scientific Files 8-K — 8-K · Feb 26, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on February 26, 2025, reporting other events and financial statements. The filing details the company's corporate s
• Kewaunee Scientific Corp Files 8-K/A Amendment — 8-K/A · Jan 16, 2025 Risk: low
  Kewaunee Scientific Corporation filed an 8-K/A on January 16, 2025, to amend a previous filing. The amendment pertains to financial statements and exhibits, wit
• Kewaunee Scientific Corp Files Q2 2025 10-Q — 10-Q · Dec 13, 2024 Risk: medium
  Kewaunee Scientific Corp reported its Q2 2025 results for the period ending October 31, 2024. The company's financial performance for the first six months of fi
• Kewaunee Scientific Files 8-K on Financials — 8-K · Dec 11, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on December 11, 2024, reporting on its results of operations and financial condition. The filing includes financial
• Kewaunee Scientific Files 8-K with Corporate Updates — 8-K · Nov 27, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on November 27, 2024, reporting other events and financial statements. The filing details the company's corporate s
• SC 13G/A Filing — SC 13G/A · Nov 1, 2024
• Kewaunee Scientific Corp Files 8-K on Asset Deal — 8-K · Nov 1, 2024 Risk: medium
  Kewaunee Scientific Corporation entered into a material definitive agreement on November 1, 2024, related to the completion of an acquisition or disposition of
• Kewaunee Scientific Files Q1 2025 10-Q — 10-Q · Sep 13, 2024 Risk: low
  Kewaunee Scientific Corp reported its 10-Q filing for the period ending July 31, 2024. The company's fiscal year ends on April 30th. The filing covers the first
• Kewaunee Scientific Corp Files 8-K on Financials — 8-K · Sep 11, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on September 11, 2024, reporting on its results of operations and financial condition. The filing includes financia
• Kewaunee Scientific Reports on Shareholder Vote Matters — 8-K · Aug 29, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on August 29, 2024, reporting on matters submitted to a vote of its security holders on August 28, 2024. The filing
• Kewaunee Scientific to be Acquired for $102.6M — 8-K · Aug 28, 2024 Risk: medium
  Kewaunee Scientific Corporation (KEQU) announced on August 28, 2024, that it has entered into a definitive agreement to be acquired by an affiliate of Sterling
• Kewaunee Scientific Files 8-K: Corporate Update — 8-K · Aug 28, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on August 28, 2024, reporting other events and financial statements. The filing details the company's principal exe
• Kewaunee Scientific Files 2024 Proxy Statement — DEF 14A · Jul 8, 2024 Risk: low
  Kewaunee Scientific Corp. is filing its definitive proxy statement (DEF 14A) for the fiscal year ending April 30, 2024, with the SEC on July 8, 2024. The filing
• Kewaunee Scientific Files 2024 10-K — 10-K · Jun 28, 2024 Risk: low
  Kewaunee Scientific Corp filed its 2024 10-K report on June 28, 2024, detailing its fiscal year ending April 30, 2024. The company, based in Statesville, NC, op
• Kewaunee Scientific Corp Files 8-K on Financials — 8-K · Jun 26, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on June 26, 2024, reporting on its results of operations and financial condition. The filing includes financial sta
• Kewaunee Scientific Files 8-K — 8-K · Jun 12, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on June 12, 2024, reporting other events and financial statements. The filing details the company's corporate infor
• Kewaunee Scientific Files 8-K — 8-K · Apr 23, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on April 23, 2024, to report other events. The filing does not contain specific details about the nature of these e
• Kewaunee Scientific Appoints Interim CFO — 8-K · Mar 22, 2024 Risk: medium
  Kewaunee Scientific Corporation announced on March 18, 2024, the appointment of David L. Dykeman as Interim Chief Financial Officer, effective immediately. Dyke
• Kewaunee Scientific Corp. Files 10-Q for Period Ending January 31, 2024 — 10-Q · Mar 8, 2024 Risk: low
  KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) filed a Quarterly Report (10-Q) with the SEC on March 8, 2024. Kewaunee Scientific Corp. filed a 10-Q report for the period
• Kewaunee Scientific Corp Files 8-K on Financials — 8-K · Mar 6, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on March 6, 2024, to report on its results of operations and financial condition. The filing includes financial sta
• Kewaunee Scientific Files 8-K on Other Events and Financial Exhibits — 8-K · Feb 21, 2024 Risk: low
  Kewaunee Scientific Corporation filed an 8-K on February 21, 2024, reporting an "Other Event" and "Financial Statements and Exhibits." The filing indicates a cu
• Northern Trust Holds 10.4% Stake in Kewaunee Scientific — SC 13G/A · Feb 13, 2024 Risk: medium
  Northern Trust Corporation, a Delaware corporation, and its subsidiary, The Northern Trust Company, filed an amended SC 13G/A on February 13, 2024, disclosing t
• Minerva Advisors Maintains Significant Stake in Kewaunee Scientific — SC 13G/A · Feb 9, 2024 Risk: medium
  Minerva Advisors LLC, along with its affiliated entities Minerva Group, LP, Minerva GP, LP, Minerva GP, Inc., and David P. Cohen, filed an amended Schedule 13G/
• Dimensional Fund Advisors Amends Kewaunee Scientific Stake — SC 13G/A · Feb 9, 2024 Risk: low
  Dimensional Fund Advisors LP, a major investment firm, filed an amended SC 13G/A on February 9, 2024, indicating a change in their ownership of Kewaunee Scienti

Risk Profile

Risk Assessment: Of KEQU's 38 recent filings, 0 were flagged as high-risk, 11 as medium-risk, and 27 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Kewaunee Scientific CORP /De/'s most recent 10-Q filing (Dec 12, 2025):

• Revenue: $70.096M
• Net Income: $2.445M
• EPS: $0.82
• Debt-to-Equity: N/A
• Cash Position: $12.594M
• Operating Margin: 5.86%
• Total Assets: N/A
• Total Debt: N/A

Key Executives

• Thomas D. Hull III
• David L. Dykeman
• David P. Cohen

Industry Context

The laboratory and technical furniture industry is characterized by project-based sales cycles and demand tied to capital spending in research, education, and healthcare sectors. Companies often compete on product customization, quality, and lead times. Recent trends may include increased demand for specialized containment solutions and flexible workspace designs.

Top Tags

financial-reporting (8) · 8-K (8) · 8-k (7) · corporate-filing (5) · 10-Q (4) · financials (4) · Laboratory Equipment (3) · sec-filing (3) · corporate-governance (3) · quarterly-report (3)

Key Numbers

• Net Sales (3 months): $70.096M — Increased 46.7% from $47.764M year-over-year
• Net Sales (6 months): $141.200M — Increased 46.8% from $96.157M year-over-year
• Net Earnings (3 months): $2.445M — Decreased 18.7% from $3.008M year-over-year
• Net Earnings (6 months): $5.538M — Increased 6.5% from $5.201M year-over-year
• Operating Expenses (3 months): $15.613M — Increased from $9.518M year-over-year
• Interest Expense (3 months): $1.061M — Increased from $0.442M year-over-year
• Nu Aire Acquisition Cost: $53.0M — Funded on November 1, 2024
• Nu Aire Revenue Contribution (3 months): $19.4M — Contributed to total net sales
• Cash and Cash Equivalents: $12.594M — Decreased from $14.942M on April 30, 2025
• Capital Expenditures (6 months): $2.341M — Increased from $0.961M year-over-year
• Net sales: $71.104M — Increased by 46.9% from $48.393M year-over-year
• Net earnings attributable to Kewaunee Scientific Corporation: $3.093M — Increased by 41.0% from $2.193M year-over-year
• Basic net earnings per share: $1.08 — Increased from $0.77 year-over-year
• Nu Aire revenue contribution: $19.7M — Revenue from Nu Aire for the three months ended July 31, 2025
• Nu Aire net earnings contribution: $696K — Net earnings from Nu Aire for the three months ended July 31, 2025

Forward-Looking Statements

• {"claim":"Northern Trust Corporation will maintain a significant stake in Kewaunee Scientific Corporation for the foreseeable future.","entity":"Northern Trust Corporation","targetDate":"2025-02-13","confidence":"medium"}
• {"claim":"Minerva Advisors will continue to engage with Kewaunee Scientific's management or board regarding strategic initiatives.","entity":"Minerva Advisors LLC","targetDate":"Within the next 12 months","confidence":"medium"}

Frequently Asked Questions